Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Antibiotic Rifaximin on the Lipopolysaccharides (LPS) and Related Cytokine Levels in Non Alcoholic Fatty Liver Disease Patients

NCT02009592 is registered in ClinicalTrials.gov with Bezmialem Vakif University as lead sponsor.

NCT NCT02009592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02009592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Antibiotic Rifaximin on the Lipopolysaccharides (LPS) and Related Cytokine Levels in Non Alcoholic Fatty Liver Disease Patients
Lead sponsor
Bezmialem Vakif University
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2013
Completion date
February 28, 2014
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fatty liver, steatohepatitis